2m 2m 2m 2m 2m 2m 2m
Theravance Bioph (TBPH)
NASDAQ
$17.02+$0.005 (+0.03%)
Price as of Sep 11, 2026 7:30 PM EDT- $1.2BMarket Cap
- 18.95%1-Year Change
- BiotechnologyIndustry
Theravance Bioph (TBPH)
$17.02+$0.005 (+0.03%)
TBPH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.01 | ||
Change | -$0.010 (-0.06%) | ||
Open | $17.06 | ||
High | $17.06 | ||
Low | $17.00 | ||
Previous Close | $17.02 | ||
Volume | 426,795 | ||
30-Day Average Volume | 383,463 | ||
1-Week Change | -0.41% | ||
1-Month Change | 0.53% | ||
1-Year Change | 18.95% | ||
3-Year Change | 68.75% | ||
5-Year Change | 101.06% | ||
Fundamentals | |||
Shares Outstanding | 73.5M | ||
Total Assets | $469.8M | ||
Market Cap | $1.2B | ||
Enterprise Value | $1.0B | ||
Period: QTR TTM FY | |||
Revenue | $20.7M | ||
Net Income | -$5.9M | ||
Free Cash Flow | -$7.0M | ||
EBIT | -$4.8M | ||
EBITDA | -$4.4M | ||
Net Working Capital | $385.9M | ||
EPS | -$0.11 | ||
Enterprise Value/EBITDA | -233 | ||
Enterprise Value/Revenue | 50 | ||
P/B | 4 | ||
P/E | -155 | ||
PEG | 15 | ||
Price/Free Cash Flow | -179 | ||
Price/Operating Cash Flow | -179 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue